Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective
Authors
Keywords
Visceral leishmaniasis, Treatment, Drug resistance, Multidrug therapy
Journal
Infectious Diseases of Poverty
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-03-08
DOI
10.1186/s40249-016-0112-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Short-Course Treatment Regimen of Indian Visceral Leishmaniasis with an Indian Liposomal Amphotericin B Preparation (Fungisome™)
- (2016) Rama P. Goswami et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Single-Dose Indigenous Liposomal Amphotericin B in the Treatment of Indian Visceral Leishmaniasis: A Phase 2 Study
- (2015) Shyam Sundar et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B
- (2015) Mohammad Asad et al. BMC INFECTIOUS DISEASES
- Asymptomatic Leishmania Infection: A New Challenge for Leishmania Control
- (2014) O. P. Singh et al. CLINICAL INFECTIOUS DISEASES
- An update on pharmacotherapy for leishmaniasis
- (2014) Shyam Sundar et al. EXPERT OPINION ON PHARMACOTHERAPY
- Post kala-azar dermal leishmaniasis: an unresolved mystery
- (2014) Debanjan Mukhopadhyay et al. TRENDS IN PARASITOLOGY
- Visceral Leishmaniasis and HIV Co-infection in Bihar, India: Long-term Effectiveness and Treatment Outcomes with Liposomal Amphotericin B (AmBisome)
- (2014) Sakib Burza et al. PLoS Neglected Tropical Diseases
- Visceral Leishmaniasis and HIV Coinfection: Time for Concerted Action
- (2014) Johan van Griensven et al. PLoS Neglected Tropical Diseases
- Strong Association between Serological Status and Probability of Progression to Clinical Visceral Leishmaniasis in Prospective Cohort Studies in India and Nepal
- (2014) Epco Hasker et al. PLoS Neglected Tropical Diseases
- How Far Are We from Visceral Leishmaniasis Elimination in Bangladesh? An Assessment of Epidemiological Surveillance Data
- (2014) Rajib Chowdhury et al. PLoS Neglected Tropical Diseases
- Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum
- (2014) Marie-Christine Brotherton et al. International Journal for Parasitology-Drugs and Drug Resistance
- Immunotherapy and Targeted Therapies in Treatment of Visceral Leishmaniasis: Current Status and Future Prospects
- (2014) Om Prakash Singh et al. Frontiers in Immunology
- Therapeutic Options for Old World Cutaneous Leishmaniasis and New World Cutaneous and Mucocutaneous Leishmaniasis
- (2013) Begoña Monge-Maillo et al. DRUGS
- Miltefosine-unresponsiveLeishmania donovanihas a greater ability than miltefosine-responsiveL. donovanito resist reactive oxygen species
- (2013) Mousumi Das et al. FEBS Journal
- Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use
- (2012) S. Sundar et al. CLINICAL INFECTIOUS DISEASES
- CE-ESI-MS metabolic fingerprinting of Leishmania resistance to antimony treatment
- (2012) Gisele A. B. Canuto et al. ELECTROPHORESIS
- Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
- (2012) T. P. C. Dorlo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- Molecular Mechanisms of Drug Resistance in Natural Leishmania Populations Vary with Genetic Background
- (2012) Saskia Decuypere et al. PLoS Neglected Tropical Diseases
- Treatment of Visceral Leishmaniasis: Model-Based Analyses on the Spread of Antimony-Resistant L. donovani in Bihar, India
- (2012) Anette Stauch et al. PLoS Neglected Tropical Diseases
- Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis
- (2012) Vasundhra Bhandari et al. PLoS Neglected Tropical Diseases
- The 8-Aminoquinoline Analogue Sitamaquine Causes Oxidative Stress in Leishmania donovani Promastigotes by Targeting Succinate Dehydrogenase
- (2011) Luis Carvalho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani
- (2011) Bidyut Purkait et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A novel mechanism for an old drug: Amphotericin B in the treatment of visceral leishmaniasis
- (2011) Amitabha Chattopadhyay et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Liposomal Amphotericin B for Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients: 2-Year Treatment Outcomes in Bihar, India
- (2011) P. K. Sinha et al. CLINICAL INFECTIOUS DISEASES
- Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance
- (2011) T. Downing et al. GENOME RESEARCH
- Miltefosine Effectively Modulates the Cytokine Milieu in Indian Post Kala-Azar Dermal Leishmaniasis
- (2011) Debanjan Mukhopadhyay et al. JOURNAL OF INFECTIOUS DISEASES
- Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
- (2011) Shyam Sundar et al. LANCET
- Paromomycin Affects Translation and Vesicle-Mediated Trafficking as Revealed by Proteomics of Paromomycin –Susceptible –Resistant Leishmania donovani
- (2011) Bhavna Chawla et al. PLoS One
- Incidence of Symptomatic and Asymptomatic Leishmania donovani Infections in High-Endemic Foci in India and Nepal: A Prospective Study
- (2011) Bart Ostyn et al. PLoS Neglected Tropical Diseases
- Effectiveness and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis under Routine Program Conditions in Bihar, India
- (2010) Prabhat K. Sinha et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Asymptomatic Infection with Visceral Leishmaniasis in a Disease-Endemic Area in Bihar, India
- (2010) Roshan K. Topno et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani
- (2010) Awanish Kumar et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Elimination of neglected tropical diseases in the South-East Asia Region of the World Health Organization
- (2010) Jai P Narain et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Amphotericin B Therapy in Children with Visceral Leishmaniasis: Daily vs. Alternate Day, a Randomized Trial
- (2010) U. K. Singh et al. JOURNAL OF TROPICAL PEDIATRICS
- Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
- (2010) Shyam Sundar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ambisome plus miltefosine for Indian patients with kala-azar
- (2010) Shyam Sundar et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Metabolomics to Unveil and Understand Phenotypic Diversity between Pathogen Populations
- (2010) Ruben t'Kindt et al. PLoS Neglected Tropical Diseases
- Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent
- (2010) Filip Meheus et al. PLoS Neglected Tropical Diseases
- Short‐Course Paromomycin Treatment of Visceral Leishmaniasis in India: 14‐Day vs 21‐Day Treatment
- (2009) Shyam Sundar et al. CLINICAL INFECTIOUS DISEASES
- Miltefosine Promotes IFN- -Dominated Anti-Leishmanial Immune Response
- (2009) P. Wadhone et al. JOURNAL OF IMMUNOLOGY
- The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India
- (2009) M. Boelaert et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism
- (2008) R. Luise Krauth-Siegel et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- New Treatment Approach in Indian Visceral Leishmaniasis: Single‐Dose Liposomal Amphotericin B Followed by Short‐Course Oral Miltefosine
- (2008) Shyam Sundar et al. CLINICAL INFECTIOUS DISEASES
- Paromomycin in the treatment of leishmaniasis
- (2008) Shyam Sundar et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started